Qiagen And Zymark Anounce Strategic Alliance

QIAGEN, N.V. and Corporation have entered into a strategic alliance addressing the use of ultra high-throughput sample and liquid handling automation.

The alliance will focus on uses of such instrumentation for nucleic acid handling and purification as well as for QIAGEN’s proprietary protein expression and purification technology.

develops and markets liquid handling platforms, which automate the Company’s market and technology leading nucleic acid handling, separation and purification consumables.

has created leading solutions for the integration of such systems into fully integrated solutions for ultra high-throughput applications.

The companies intend to develop and launch systems which will combine QIAGEN’s BioRobot automated instrumentation platforms with Zymark’s RapidPlate 96-well and 384-well pipetting solutions and Zymark’s Staccato and Twister systems to address the rapidly expanding need for ultra high-throughput nucleic acid handling, separation and purification solutions in the genomics markets.

and also intend to enter into research and development programs to expand the uses of the combination of each company’s instrumentation components with QIAGEN’ nucleic acid handling, separation and purification consumable technologies.

Corporation President and CEO Kevin Hrusovsky stated, and Zymark’s collaboration to integrate chemistries and automation represents a significant opportunity to further advance the throughput of nucleic acid purification, and ensures that QIAGEN’s customer base will realize maximum benefit from the utilization of these powerful technologies.”

N.V., provides innovative enabling technologies and products for the separation, purification and handling of nucleic acids.

The Company has developed a comprehensive portfolio of more than 300 proprietary, consumable products for nucleic acid separation, purification and handling, nucleic acid amplification, as well as automated instrumentation, synthetic nucleic acid products and related services.

Corporation is a premier provider of products, technologies and services for laboratory applications in the rapidly growing markets of life science.

is focused exclusively on laboratory automation and robotic solutions.

Shopping Dragon Pharma Labs

Propionat 100 - Bulk Price

Administration: Injection
Principal Component: Testosterone Propionate
Manufacturer: Dragon Pharma
Pack: 10 x 10 mL vial (100 mg/mL)
Price: 10 x $30.00

TriTren 150 - Cheap Price

Administration: Injection
Base Chemical Name: Tri Trenbolone
Manufacturer: Dragon Pharmaceutical
Unit: 20 x 10 mL vial (150 mg/mL)
Price: 20 x $65.00

Sustanon 350

Injectable Anabolic Steroid
Base Component: Testosterone Blend
Branded by: Dragon Pharmaceuticals
Package: 1 X 10 ml (350 mg/ml)

Primobolan 200

Injectable Anabolic Steroid
Active Component: Methenolone Enanthate
Produced by: Dragon Pharma Labs
Amount: 1 X 10 mL vial (200 mg/mL)


Oral Steroid for Muscle Growth
Basal Constituent: Oxandrolone
Produced by: Dragon Pharma LLC
100 pills (50 mg/tab)

EQ 500

Injectable Steroid for Muscle Growth
Prime Component: Boldenone Undecylenate
Branded by: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (500 mg/mL)

EQ 300

Injectable Steroid for Muscle Growth
Base Substance: Boldenone Undecylenate
Manufacturer: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (300 mg/mL)

Winstrol Tabs

Main Substance: Stanozolol
Producer: Dragon Pharma Labs
Package: 100 pastilles (50 mg/pill)

Cypionat 250

Primary Constituent: Testosterone Cypionate
Made by: Dragon Pharmaceutical
Pack: 10 x 10 mL vial (250 mg/mL)

TriTren 150

Main Constituent: Tri Trenbolone
Made by: Dragon Pharma
Amount: 10 x 10 mL vial (150 mg/mL)

Deca 500

Prime Ingredient: Nandrolone Decanoate
Branded by: Dragon Pharmaceutical
Package: 10 mL vial (500 mg/mL)

Masteron 100

Prime Constituent: Drostanolone Di-Propionate
Manufacturer: Dragon Pharmaceuticals
Unit: 10 mL vial (100 mg/mL)